Viewing StudyNCT00528333



Ignite Creation Date: 2024-05-05 @ 6:40 PM
Last Modification Date: 2024-10-26 @ 9:36 AM
Study NCT ID: NCT00528333
Status: COMPLETED
Last Update Posted: 2015-01-07
First Post: 2007-09-10

Brief Title: A Study of Lintuzumab SGN-33 in Combination With Low Dose Cytarabine in Patients 60 Years With AML
Sponsor: Seagen Inc
Organization: Seagen Inc

Key Dates - Follows AllAPIJSON File Order

Start Date: 2007-09
Start Date Type: None
Primary Completion Date: 2010-08
Primary Completion Date Type: ACTUAL
Completion Date: 2010-08
Completion Date Type: ACTUAL
First Submit Date: 2007-09-10
First Submit QC Date: September 11 2007
Study First Post Date: 2007-09-12
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: 2011-10-07
Disp First Submit QC Date: October 7 2011
Disp First Post Date: 2011-10-12
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2014-12-17
Last Update Post Date: 2015-01-07
Last Update Post Date Type: ESTIMATED